Malignant peripheral nerve sheath tumor screening

Malignant peripheral nerve sheath tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Malignant peripheral nerve sheath tumor screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Malignant peripheral nerve sheath tumor screening
CDC on Malignant peripheral nerve sheath tumor screening
Malignant peripheral nerve sheath tumor screening in the news
Blogs on Malignant peripheral nerve sheath tumor screening
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor
Risk calculators and risk factors for Malignant peripheral nerve sheath tumor screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for malignant peripheral nerve sheath tumor.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for malignant peripheral nerve sheath tumor.

References

Template:WikiDoc Sources